Search Results - "BECHERINI, Pamela"
-
1
Mesenchymal Stem Cell‐Derived Extracellular Vesicles as Mediators of Anti‐Inflammatory Effects: Endorsement of Macrophage Polarization
Published in Stem cells translational medicine (01-03-2017)“…Mesenchymal Stem Cells (MSCs) are effective therapeutic agents enhancing the repair of injured tissues mostly through their paracrine activity. Increasing…”
Get full text
Journal Article -
2
Fasting-mimicking diet and hormone therapy induce breast cancer regression
Published in Nature (London) (23-07-2020)“…Approximately 75% of all breast cancers express the oestrogen and/or progesterone receptors. Endocrine therapy is usually effective in these…”
Get full text
Journal Article -
3
Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair
Published in Cancer research (Chicago, Ill.) (15-07-2017)“…In the last decade, substantial efforts have been made to identify NAD biosynthesis inhibitors, specifically against nicotinamide phosphoribosyltransferase…”
Get full text
Journal Article -
4
Cyclic fasting bolsters cholesterol biosynthesis inhibitors’ anticancer activity
Published in Nature communications (31-10-2023)“…Identifying oncological applications for drugs that are already approved for other medical indications is considered a possible solution for the increasing…”
Get full text
Journal Article -
5
Author Correction: Cyclic fasting bolsters cholesterol biosynthesis inhibitors’ anticancer activity
Published in Nature communications (22-11-2023)Get full text
Journal Article -
6
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment
Published in Haematologica (Roma) (01-06-2022)“…Identification of novel vulnerabilities in the context of therapeutic resistance is emerging as a key challenge for cancer treatment. Recent studies have…”
Get full text
Journal Article -
7
Transcriptome analysis defines myocardium gene signatures in children with ToF and ASD and reveals disease-specific molecular reprogramming in response to surgery with cardiopulmonary bypass
Published in Journal of translational medicine (10-01-2020)“…Tetralogy of Fallot (ToF) and Atrial Septal Defects (ASD) are the most common types of congenital heart diseases and a major cause of childhood morbidity and…”
Get full text
Journal Article -
8
Tumor Regression and Curability of Preclinical Neuroblastoma Models by PEGylated SN38 (EZN-2208), a Novel Topoisomerase I Inhibitor
Published in Clinical cancer research (01-10-2010)“…Treatment of neuroblastoma is successful in less than half of patients with high-risk disease. The antitumor activity of a water soluble pegylated SN38 drug…”
Get full text
Journal Article -
9
SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice
Published in Cancer & metabolism (22-01-2021)“…Sirtuin 6 (SIRT6) is a NAD -dependent deacetylase with key roles in cell metabolism. High SIRT6 expression is associated with adverse prognosis in breast…”
Get full text
Journal Article -
10
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma
Published in Journal of controlled release (01-07-2010)“…The therapeutic index of anti-cancer drugs is increased when encapsulating them in tumor-targeted liposomes. Liposome-entrapped doxorubicin (DXR), targeting…”
Get full text
Journal Article -
11
SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells
Published in The FASEB journal (01-03-2019)Get full text
Journal Article -
12
Abstract 5609: Bortezomib enhanced cytotoxic effects of novel sTRAIL-targeted nanocarriers against neuroectodermal tumors
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract The soluble form of the tumor necrosis factor (TNF)-related apoptosis-inducing ligand (sTRAIL) is a cancer cell-specific molecule exerting anti-tumor…”
Get full text
Journal Article -
13
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD + -Lowering Agents
Published in Antioxidants (01-02-2023)“…Cancer cells fuel growth and energy demands by increasing their NAD biosynthesis dependency, which therefore represents an exploitable vulnerability for…”
Get full text
Journal Article -
14
The use of the orthotopic model to validate antivascular therapies for cancer
Published in The International journal of developmental biology (2011)“…The orthotopic model reproduces aspects of the tumour microenvironment and emulates a number of important biological features of cancer progression,…”
Get full text
Journal Article -
15
The Multi-Kinases Inhibitor ARQ531 Enhanches Anti-MM Activity of Imids By Dual Deregulation of MAP- and Cyclin-Dependent Kinases Activities
Published in Blood (15-11-2022)Get full text
Journal Article -
16
SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells
Published in The FASEB journal (01-03-2019)“…ABSTRACT Nicotinamide phosphoribosyltransferase (NAMPT) is the rate‐limiting enzyme in the NAD+ salvage pathway from nicotinamide. By controlling the…”
Get full text
Journal Article -
17
The NAD + Metabolic Dependency Restriction Overcomes Drug-Resistance Phenotype of Multiple Myeloma CELLS
Published in Blood (02-11-2023)“…Introduction: We previously reported that Nicotinamide Adenine Dinucleotide (NAD +), a master regulator of catabolic metabolism and several enzymatic…”
Get full text
Journal Article -
18
Clonal Hematopoiesis: Exploiting Molecular Landscape of Multiple Myeloma Patients for Choosing the Most Appropriate Therapeutic Strategy
Published in Blood (15-11-2022)Get full text
Journal Article -
19
First Characterization of Human Amniotic Fluid Stem Cell Extracellular Vesicles as a Powerful Paracrine Tool Endowed with Regenerative Potential
Published in Stem cells translational medicine (01-05-2017)“…Human amniotic fluid stem cells (hAFS) have shown a distinct secretory profile and significant regenerative potential in several preclinical models of disease…”
Get full text
Journal Article -
20
Higher CD56 Expression on Multiple Myeloma Cells Increases CD38 Expression, Reduces Intracellular NAD+ Levels, and Enhances the Efficacy of Daratumumab-Based Treatment Strategies
Published in Blood (02-11-2023)“…NCAM1 (Neural Cell Adhesion Molecule 1), also known as CD56, is a member of the immunoglobulin superfamily and is deregulated in many tumors. In multiple…”
Get full text
Journal Article